Axogen Inc
(FRA:LT3)
€
6.5
-0.05 (-0.76%)
Market Cap: 276.97 Mil
Enterprise Value: 324.91 Mil
PE Ratio: 0
PB Ratio: 3.19
GF Score: 63/100 - Q1 2024 AxoGen Inc Earnings Call TranscriptMay 02, 2024€5.95 (-2.46%)Earnings
- Q4 2023 AxoGen Inc Earnings Call TranscriptMar 05, 2024€9.6 (-1.54%)Earnings
- Q3 2023 AxoGen Inc Earnings Call TranscriptNov 07, 2023€3.52 (-2.76%)Earnings
- AxoGen Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Q2 2023 AxoGen Inc Earnings Call TranscriptAug 07, 2023€7.4 (-0.67%)Earnings
- AxoGen Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- AxoGen Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 AxoGen Inc Earnings Call TranscriptMay 09, 2023€8.65Earnings
- Q4 2022 AxoGen Inc Earnings Call TranscriptMar 14, 2023€6.95 (+1.46%)Earnings
- AxoGen Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- AxoGen Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 AxoGen Inc Earnings call TranscriptNov 08, 2022€11.1 (+1.83%)Earnings
- Q2 2022 AxoGen Inc Earnings Call TranscriptAug 03, 2022€10.1 (+8.02%)Earnings
- Q1 2022 AxoGen Inc Earnings Call TranscriptMay 04, 2022€7.2 (-2.04%)Earnings
- Q4 2021 AxoGen Inc Earnings Call TranscriptFeb 22, 2022€6.45 (+0.78%)Earnings
- Q3 2021 AxoGen Inc Earnings Call TranscriptNov 03, 2021€13.1Earnings
- Q2 2021 AxoGen Inc Earnings Call TranscriptAug 04, 2021€16.6 (-2.35%)Earnings
- AxoGen Inc Annual Shareholders Meeting TranscriptMay 10, 2021
- Q1 2021 AxoGen Inc Earnings Call TranscriptMay 05, 2021€15.9Earnings
- Q4 2020 AxoGen Inc Earnings Call TranscriptFeb 22, 2021€16.9 (+4.32%)Earnings
- Q3 2020 AxoGen Inc Earnings Call TranscriptOct 29, 2020€10.4 (-0.95%)Earnings
- Q2 2020 AxoGen Inc Earnings Call TranscriptAug 05, 2020€10 (+3.63%)Earnings
- AxoGen Inc Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 AxoGen Inc Earnings Call TranscriptMay 06, 2020€8.75 (-0.57%)Earnings
- Q4 2019 AxoGen Inc Earnings Call TranscriptFeb 24, 2020€13.4 (-0.74%)Earnings
- AxoGen Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 AxoGen Inc Earnings Call TranscriptNov 06, 2019€12 (-1.64%)Earnings
- AxoGen Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptOct 02, 2019
- AxoGen Inc Annual Shareholders Meeting TranscriptAug 14, 2019
- Q2 2019 AxoGen Inc Earnings Call TranscriptAug 06, 2019€15.1 (+0.60%)Earnings
- Q1 2019 AxoGen Inc Earnings Call TranscriptMay 08, 2019€20.19 (-7.43%)Earnings
- AxoGen Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 AxoGen Inc Earnings Call TranscriptFeb 26, 2019€15.56 (-2.08%)Earnings
AxoGen Inc at Jefferies London Healthcare Conference Transcript
Nov 15, 2022 / 10:20AM GMT
Release Date Price:
€11.8
(-4.84%)
Mike Sarcone
UBS Securities LLC - Analyst
My name is Mike Sarcone. I work on the US Medical Supplies and Devices team. And with us today, we're happy to have Axogen. And from the team, we've got Karen Zaderej, Chairperson, President, and CEO; and Pete Mariani, Executive Vice President and CFO.
Karen, Pete, thank you for joining us.
Karen Zaderej
Axogen, Inc. - Chairman, CEO & President
Thank you.
Pete Mariani
Axogen, Inc. - EVP & CFO
Thank you.
Questions & Answers
Mike Sarcone
UBS Securities LLC - Analyst
So I guess just to kick it off for those who are newer to the story, do you think you can give us a quick overview of Axogen's product offering and applications and the value proposition versus standard of care? And then just secondly to that, can you touch on the progress you've made over the past few years in terms of driving adoption?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)